BPMUF
Price
$57.70
Change
+$10.20 (+21.47%)
Updated
Jun 6 closing price
Capitalization
728.58M
SRPT
Price
$17.11
Change
-$0.12 (-0.70%)
Updated
Jun 27 closing price
Capitalization
1.68B
31 days until earnings call
Interact to see
Advertisement

BPMUF vs SRPT

Header iconBPMUF vs SRPT Comparison
Open Charts BPMUF vs SRPTBanner chart's image
Basilea Pharmaceutica AG
Price$57.70
Change+$10.20 (+21.47%)
Volume$22
Capitalization728.58M
Sarepta Therapeutics
Price$17.11
Change-$0.12 (-0.70%)
Volume$4.73M
Capitalization1.68B
BPMUF vs SRPT Comparison Chart in %
Loading...
BPMUF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BPMUF vs. SRPT commentary
Jun 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BPMUF is a Hold and SRPT is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2025
Stock price -- (BPMUF: $57.70 vs. SRPT: $17.11)
Brand notoriety: BPMUF: Not notable vs. SRPT: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BPMUF: 158% vs. SRPT: 79%
Market capitalization -- BPMUF: $728.58M vs. SRPT: $1.68B
BPMUF [@Biotechnology] is valued at $728.58M. SRPT’s [@Biotechnology] market capitalization is $1.68B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BPMUF’s FA Score shows that 0 FA rating(s) are green whileSRPT’s FA Score has 0 green FA rating(s).

  • BPMUF’s FA Score: 0 green, 5 red.
  • SRPT’s FA Score: 0 green, 5 red.
According to our system of comparison, BPMUF is a better buy in the long-term than SRPT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BPMUF’s TA Score shows that 3 TA indicator(s) are bullish while SRPT’s TA Score has 3 bullish TA indicator(s).

  • BPMUF’s TA Score: 3 bullish, 3 bearish.
  • SRPT’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, BPMUF is a better buy in the short-term than SRPT.

Price Growth

BPMUF (@Biotechnology) experienced а 0.00% price change this week, while SRPT (@Biotechnology) price change was -14.79% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

SRPT is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SRPT($1.68B) has a higher market cap than BPMUF($729M). SRPT has higher P/E ratio than BPMUF: SRPT (27.21) vs BPMUF (7.96). BPMUF YTD gains are higher at: 9.218 vs. SRPT (-85.928).
BPMUFSRPTBPMUF / SRPT
Capitalization729M1.68B43%
EBITDAN/A-106.51M-
Gain YTD9.218-85.928-11%
P/E Ratio7.9627.2129%
RevenueN/A2.23B-
Total CashN/A523M-
Total DebtN/A1.34B-
FUNDAMENTALS RATINGS
BPMUF vs SRPT: Fundamental Ratings
BPMUF
SRPT
OUTLOOK RATING
1..100
5052
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
62
Fair valued
PROFIT vs RISK RATING
1..100
72100
SMR RATING
1..100
10095
PRICE GROWTH RATING
1..100
4398
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5040

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SRPT's Valuation (62) in the Biotechnology industry is in the same range as BPMUF (77) in the null industry. This means that SRPT’s stock grew similarly to BPMUF’s over the last 12 months.

BPMUF's Profit vs Risk Rating (72) in the null industry is in the same range as SRPT (100) in the Biotechnology industry. This means that BPMUF’s stock grew similarly to SRPT’s over the last 12 months.

SRPT's SMR Rating (95) in the Biotechnology industry is in the same range as BPMUF (100) in the null industry. This means that SRPT’s stock grew similarly to BPMUF’s over the last 12 months.

BPMUF's Price Growth Rating (43) in the null industry is somewhat better than the same rating for SRPT (98) in the Biotechnology industry. This means that BPMUF’s stock grew somewhat faster than SRPT’s over the last 12 months.

BPMUF's P/E Growth Rating (100) in the null industry is in the same range as SRPT (100) in the Biotechnology industry. This means that BPMUF’s stock grew similarly to SRPT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BPMUFSRPT
RSI
ODDS (%)
Bearish Trend 3 days ago
25%
Bullish Trend 3 days ago
76%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
11%
Bullish Trend 3 days ago
79%
Momentum
ODDS (%)
N/A
Bearish Trend 3 days ago
80%
MACD
ODDS (%)
Bearish Trend 3 days ago
19%
Bearish Trend 3 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
15%
Bearish Trend 3 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
11%
Bearish Trend 3 days ago
77%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
Bearish Trend 3 days ago
79%
BollingerBands
ODDS (%)
N/A
Bullish Trend 3 days ago
61%
Aroon
ODDS (%)
Bearish Trend 3 days ago
14%
Bearish Trend 3 days ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
BPMUF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MBCLX23.360.22
+0.95%
MassMutual Blue Chip Growth Adm
DODWX15.750.13
+0.83%
Dodge & Cox Global Stock I
NWKAX15.280.08
+0.53%
Nationwide Geneva Mid Cap Gr R6
PCAFX22.990.02
+0.09%
Prospector Capital Appreciation
GTTUX53.260.01
+0.02%
Goldman Sachs Small Cp Val Insghts R6

BPMUF and

Correlation & Price change

A.I.dvisor indicates that over the last year, BPMUF has been loosely correlated with SRPT. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if BPMUF jumps, then SRPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BPMUF
1D Price
Change %
BPMUF100%
N/A
SRPT - BPMUF
52%
Loosely correlated
-0.70%
AAVXF - BPMUF
47%
Loosely correlated
N/A
ABCZF - BPMUF
38%
Loosely correlated
N/A
ALZN - BPMUF
30%
Poorly correlated
-0.68%
INM - BPMUF
27%
Poorly correlated
-2.31%
More

SRPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, SRPT has been loosely correlated with BPMUF. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if SRPT jumps, then BPMUF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRPT
1D Price
Change %
SRPT100%
-0.70%
BPMUF - SRPT
52%
Loosely correlated
N/A
AAVXF - SRPT
45%
Loosely correlated
N/A
RCKT - SRPT
42%
Loosely correlated
-2.90%
SLDB - SRPT
41%
Loosely correlated
-1.87%
NXTC - SRPT
38%
Loosely correlated
-2.17%
More